These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 21353959

  • 1. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
    Lagacé-Wiens PR, Simner PJ, Forward KR, Tailor F, Adam HJ, Decorby M, Karlowsky J, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD, MacDonald N, Fuite L, Chan F, Stephens D.
    CMAJ; 1999 May 18; 160(10):1436-40. PubMed ID: 10352632
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):263-8. PubMed ID: 19734603
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J.
    J Clin Microbiol; 2001 Feb 01; 39(2):438-44. PubMed ID: 11158087
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.
    Karlowsky JA, Lagacé-Wiens PRS, Adam HJ, Baxter MR, Laing NM, Walkty AJ, Zhanel GG.
    Int J Antimicrob Agents; 2019 Jul 01; 54(1):62-68. PubMed ID: 31034938
    [Abstract] [Full Text] [Related]

  • 6. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents].
    Kot B, Wicha J, Zak-Puławska Z.
    Przegl Epidemiol; 2010 Jul 01; 64(2):307-12. PubMed ID: 20731243
    [Abstract] [Full Text] [Related]

  • 7. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for E. coli Urinary Pathogens.
    Rev Esp Quimioter; 2007 Jun 01; 20(2):206-10. PubMed ID: 17893757
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagacé-Wiens PR, Adam HJ, Hoban DJ, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2011 Mar 01; 69(3):326-34. PubMed ID: 21353961
    [Abstract] [Full Text] [Related]

  • 9. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.
    Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA.
    Antimicrob Agents Chemother; 2001 May 01; 45(5):1402-6. PubMed ID: 11302802
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 01; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, NAUTICA Group.
    Int J Antimicrob Agents; 2005 Nov 15; 26(5):380-8. PubMed ID: 16243229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S, Terporten PH, Hoogkamp-Korstanje JA, Stobberingh EE, Susceptibility Surveillance Study Group.
    J Antimicrob Chemother; 2008 Jul 15; 62(1):126-32. PubMed ID: 18417487
    [Abstract] [Full Text] [Related]

  • 15. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):257-62. PubMed ID: 19734602
    [Abstract] [Full Text] [Related]

  • 16. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV, Baird AM, Karlowsky JA, Master RN, Bordon JM.
    J Antimicrob Chemother; 2014 Dec 01; 69(12):3259-62. PubMed ID: 25063776
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010.
    Hoban DJ, Nicolle LE, Hawser S, Bouchillon S, Badal R.
    Diagn Microbiol Infect Dis; 2011 Aug 01; 70(4):507-11. PubMed ID: 21767706
    [Abstract] [Full Text] [Related]

  • 18. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T, Ozyurt M, Baylan O, Bektöre B, Ardiç N, Ceylan S, Erdemoğlu A, Haznedaroğlu T.
    Mikrobiyol Bul; 2009 Oct 01; 43(4):645-9. PubMed ID: 20084918
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G, Poulsen HO.
    Int J Antimicrob Agents; 2012 Jan 01; 39(1):45-51. PubMed ID: 22055529
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for Urinary Pathogens.
    Rev Esp Quimioter; 2007 Mar 01; 20(1):68-76. PubMed ID: 17530038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.